HEARTMATE 3 LVAS IMPLANT KIT
Report
- Report Number
- 2916596-2022-10879
- Event Type
- Death
- Date Received
- May 20, 2022
- Date of Event
- April 28, 2022
- Report Date
- June 29, 2022
- Manufacturer
- THORATEC CORPORATION
- Product Code
- DSQ
- PMA / PMN Number
- P160054
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
MANUFACTURER'S INVESTIGATION CONCLUSION: A DIRECT CORRELATION BETWEEN THE HEARTMATE (HM) 3 LEFT VENTRICULAR ASSIST SYSTEM (LVAS), (B)(6), AND THE REPORTED CARDIAC ARRHYTHMIA COULD NOT BE CONCLUSIVELY ESTABLISHED THROUGH THIS INVESTIGATION. (B)(6) WAS RETURNED ASSEMBLED WITH THE PUMP CABLE SEVERED APPROXIMATELY 10.5 INCHES FROM THE PUMP HEADER. THE DISTAL PORTION OF THE PUMP CABLE AND THE MODULAR CABLE WERE NOT RETURNED. THE SEALED OUTFLOW GRAFT WAS RETURNED IN 2 PARTS, BOTH MEASURING APPROXIMATELY 3.5 INCHES. THE PROXIMAL PORTION OF THE SEALED OUTFLOW GRAFT WAS RETURNED ATTACHED TO THE PUMP COVER OUTLET PORT WITH THE BEND RELIEF ENGAGED TO THE GRAFT ATTACHMENT. THE APICAL CUFF WAS RETURNED SECURED WITH THE CUFF LOCK FULLY ENGAGED. UPON DISASSEMBLY OF THE RETURNED PUMP, VISUAL INSPECTION OF THE BLOOD-CONTACTING SURFACES DID NOT REVEAL ANY ADHERED DEPOSITIONS OR THROMBUS FORMATIONS. COAGULATED BLOOD WAS FOUND IN THE OUTFLOW GRAFT, PUMP OUTFLOW, PUMP COVER, AND ROTOR. THE LVAD EVENT AND PERIODIC LOG FILES RETRIEVED FROM THE RETURNED DEVICE APPEARED TO CAPTURE THE DEVICE FUNCTIONING AS INTENDED. (B)(6) WAS CLEANED, REBUILT, AND FUNCTIONALLY TESTED ON A MOCK CIRCULATORY LOOP. THE DEVICE OPERATED AS INTENDED AND IN ACCORDANCE WITH MANUFACTURING SPECIFICATIONS. THE RELEVANT SECTIONS OF THE DEVICE HISTORY RECORDS FOR (B)(6) WERE REVIEWED AND SHOWED NO DEVIATIONS FROM MANUFACTURING OR QUALITY ASSURANCE SPECIFICATIONS. THE IMPLANT KIT WAS SHIPPED ON 21APR2022. THE HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM INSTRUCTIONS FOR USE LISTS CARDIAC ARRHYTHMIA AS AN ADVERSE EVENT, AS WELL AS A POTENTIAL LATE POSTIMPLANT COMPLICATION THAT MAY BE ASSOCIATED WITH THE USE OF THE HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM. NO FURTHER INFORMATION WAS PROVIDED. THE MANUFACTURER IS CLOSING THE FILE ON THIS EVENT.
NO FURTHER INFORMATION WAS PROVIDED. A SUPPLEMENTAL REPORT WILL BE SUBMITTED ONCE THE MANUFACTURER¿S INVESTIGATION IS COMPLETED.
IT WAS REPORTED THAT THE PATIENT HAD RHYTHM DISTURBANCES PRIOR TO IMPLANT AND WERE CAUSED BY SEVERAL MEDICAL TREATMENTS.
IT WAS REPORTED THAT ON (B)(6) 2022 THE PATIENT PASSED AWAY DUE TO MALIGNANT RHYTHM DISTURBANCE. THE PATIENT HAD RECURRENT VENTRICULAR TACHYCARDIA STORM AND VENTRICULAR FIBRILLATION. THE PATIENT WAS RECEIVING END STAGE MEDICAL THERAPY WITH HIGH DOSE AJMALINE AND AMIODARONE INTRAVENOUSLY. THE PATIENT WAS SHOCKED WITHOUT SUCCESS. THE DEATH WAS NOT BELIEVED TO BE DEVICE RELATED AND THE DEVICE WAS OPERATING AS EXPECTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1191280 | HEARTMATE 3 LVAS IMPLANT KIT | VENTRICULAR (ASSIST) BYPASS | DSQ | THORATEC CORPORATION | 106524INT | 8240150 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Death |